717 related articles for article (PubMed ID: 20511548)
1. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype.
Ghannam S; Pène J; Moquet-Torcy G; Jorgensen C; Yssel H
J Immunol; 2010 Jul; 185(1):302-12. PubMed ID: 20511548
[TBL] [Abstract][Full Text] [Related]
2. CCL20 and β-defensin-2 induce arrest of human Th17 cells on inflamed endothelium in vitro under flow conditions.
Ghannam S; Dejou C; Pedretti N; Giot JP; Dorgham K; Boukhaddaoui H; Deleuze V; Bernard FX; Jorgensen C; Yssel H; Pène J
J Immunol; 2011 Feb; 186(3):1411-20. PubMed ID: 21178014
[TBL] [Abstract][Full Text] [Related]
3. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R
Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor.
Duffy MM; Pindjakova J; Hanley SA; McCarthy C; Weidhofer GA; Sweeney EM; English K; Shaw G; Murphy JM; Barry FP; Mahon BP; Belton O; Ceredig R; Griffin MD
Eur J Immunol; 2011 Oct; 41(10):2840-51. PubMed ID: 21710489
[TBL] [Abstract][Full Text] [Related]
5. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.
Cuerquis J; Romieu-Mourez R; François M; Routy JP; Young YK; Zhao J; Eliopoulos N
Cytotherapy; 2014 Feb; 16(2):191-202. PubMed ID: 24438900
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory effects of ex vivo human Th17 cells are suppressed by regulatory T cells.
Crome SQ; Clive B; Wang AY; Kang CY; Chow V; Yu J; Lai A; Ghahary A; Broady R; Levings MK
J Immunol; 2010 Sep; 185(6):3199-208. PubMed ID: 20720207
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow-derived mesenchymal stem cells favor the immunosuppressive T cells skewing in a Helicobacter pylori model of gastric cancer.
Lin R; Ma H; Ding Z; Shi W; Qian W; Song J; Hou X
Stem Cells Dev; 2013 Nov; 22(21):2836-48. PubMed ID: 23777268
[TBL] [Abstract][Full Text] [Related]
8. IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation.
Zhang X; Jin J; Tang Y; Speer D; Sujkowska D; Markovic-Plese S
J Immunol; 2009 Mar; 182(6):3928-36. PubMed ID: 19265172
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
Luz-Crawford P; Kurte M; Bravo-Alegría J; Contreras R; Nova-Lamperti E; Tejedor G; Noël D; Jorgensen C; Figueroa F; Djouad F; Carrión F
Stem Cell Res Ther; 2013 Jun; 4(3):65. PubMed ID: 23734780
[TBL] [Abstract][Full Text] [Related]
10. IFN-beta inhibits human Th17 cell differentiation.
Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
[TBL] [Abstract][Full Text] [Related]
11. Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activation.
Carrión F; Nova E; Luz P; Apablaza F; Figueroa F
Immunol Lett; 2011 Mar; 135(1-2):10-6. PubMed ID: 20888363
[TBL] [Abstract][Full Text] [Related]
12. Activated T-cells and pro-inflammatory cytokines differentially regulate prostaglandin E2 secretion by mesenchymal stem cells.
Hegyi B; Kudlik G; Monostori E; Uher F
Biochem Biophys Res Commun; 2012 Mar; 419(2):215-20. PubMed ID: 22333568
[TBL] [Abstract][Full Text] [Related]
13. Reduced CD18 levels drive regulatory T cell conversion into Th17 cells in the CD18hypo PL/J mouse model of psoriasis.
Singh K; Gatzka M; Peters T; Borkner L; Hainzl A; Wang H; Sindrilaru A; Scharffetter-Kochanek K
J Immunol; 2013 Mar; 190(6):2544-53. PubMed ID: 23418628
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells.
Leveque L; Deknuydt F; Bioley G; Old LJ; Matsuzaki J; Odunsi K; Ayyoub M; Valmori D
J Immunother; 2009; 32(2):101-8. PubMed ID: 19238008
[TBL] [Abstract][Full Text] [Related]
15. Systemic transplantation of allogenic fetal membrane-derived mesenchymal stem cells suppresses Th1 and Th17 T cell responses in experimental autoimmune myocarditis.
Ohshima M; Yamahara K; Ishikane S; Harada K; Tsuda H; Otani K; Taguchi A; Miyazato M; Katsuragi S; Yoshimatsu J; Kodama M; Kangawa K; Ikeda T
J Mol Cell Cardiol; 2012 Sep; 53(3):420-8. PubMed ID: 22796574
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
[TBL] [Abstract][Full Text] [Related]
17. Human adipose tissue-derived mesenchymal stem cells induce explosive T-cell proliferation.
Crop MJ; Baan CC; Korevaar SS; Ijzermans JN; Weimar W; Hoogduijn MJ
Stem Cells Dev; 2010 Dec; 19(12):1843-53. PubMed ID: 20367242
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory effects of adipose-derived mesenchymal stem cells on the gene expression of major transcription factors of T cell subsets.
Mohammadzadeh A; Pourfathollah AA; Shahrokhi S; Hashemi SM; Moradi SL; Soleimani M
Int Immunopharmacol; 2014 Jun; 20(2):316-21. PubMed ID: 24704622
[TBL] [Abstract][Full Text] [Related]
19. The effect of pro-inflammatory cytokines on immunophenotype, differentiation capacity and immunomodulatory functions of human mesenchymal stem cells.
Pourgholaminejad A; Aghdami N; Baharvand H; Moazzeni SM
Cytokine; 2016 Sep; 85():51-60. PubMed ID: 27288632
[TBL] [Abstract][Full Text] [Related]
20. Interplay between CD45RA+ regulatory T cells and TNF-alpha in the regulation of human Th17 differentiation.
Baba N; Rubio M; Sarfati M
Int Immunol; 2010 Apr; 22(4):237-44. PubMed ID: 20181653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
